Klein Matthew B. sold PTCT
January 8, 2026 · Form 4 insider transaction
Klein Matthew B. sold 2,514 shares of PTC Therapeutics, Inc. at $76.45 per share, a transaction worth $192.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,514
Price
$76.45
Total value
$192.2K
InsiderKlein Matthew B.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 8, 2026
Filing dateJanuary 12, 2026
Shares owned after394,453
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to irrevocable sell to cover elections entered into upon acceptance of the respective grants to satisfy tax withholding obligations in connection with the vesting of 5,250 RSUs from a January 7, 2022 grant of 21,000 RSUs.